Quote For AmerisourceBergen Corporation ABC.N
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
27 Nov 2009
24.86USD
$24.86
27 Nov 2009
-0.48%
$24.98
$24.55
465,700
$25.03
$24.49
$25.11
$13.75
0.74
3,050,031
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Gozon, Richard |
Chairman of the Board |
-- |
| Yost, R. David |
President, Chief Executive Officer, Director |
5,711,013 |
| DiCandilo, Michael |
Chief Financial Officer, Executive Vice President; COO - AmerisourceBergen Drug Corporation |
2,525,369 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$7,389.81 |
| Shares Outstanding (Mil.) |
297.26 |
| Float (Mil.) |
292.80 |
| |
| Dividend Information |
| Yield % |
1.29 |
| Annual Dividend ($ USD) |
-- |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
0.53 |
| Current Ratio |
1.05 |
| LT Debt/Equity |
43.33 |
| Total Debt/Equity |
43.37 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
14.76 |
| Price/Sales(TTM) |
0.10 |
| Price/Book(TTM) |
2.72 |
| Price/Cash Flow(TTM) |
12.51 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$1.70 |
| Sales(TTM) |
$236.01 |
| Book Value(MRQ) |
$9.14 |
| Cash Flow(TTM) |
$1.94 |
| Cash(MRQ) |
$3.40 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
18.86 |
| Return on Assets(TTM) |
3.97 |
| Return on Investment(TTM) |
12.57 |
| |
|
| Margins |
| Gross Margin(TTM) % |
2.93 |
| Operating Margin(TTM) % |
1.23 |
| Profit Margin(TTM) % |
0.71 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives